Timothy Gray - 19 Aug 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Aug 2025, 09:19:26 UTC
Prior SEC filing
23 May 2025
Next SEC filing
23 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
s/ Gena L. Ashe, Attorney-in-Fact

Key filing fact

Timothy Gray filed Form 4 for Anterix Inc. (ATEX) on 21 Aug 2025.

Key facts

  • This page summarizes Timothy Gray's Form 4 filing for Anterix Inc. (ATEX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Aug 2025, 09:19.

Change

  • Previous filing in this sequence was filed on 23 May 2025.
  • Current net transaction value: +$1,104.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001629762 Primary reporting owner

Gray Timothy

Relationship
Chief Financial Officer
Address
3 GARRET MOUNTAIN PLAZA, SUITE 401, WOODLAND PARK
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Signature date
20 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATEX transaction

Common Stock

Purchase

Transaction value
$1,104
Shares
+50
Change %
+0.06%
Price
$22.07
Shares after
77,022
Date
19 Aug 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .